Clinical Trial Update: 0.3% Sodium Hyaluronate Eye Drop to Prevent Recurrent Corneal Epithelium Exfoliation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating 0.3% sodium hyaluronate eye drops to prevent recurrent corneal epithelial erosion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Epithelial Erosion

Drugs mentioned

• 0.3% Sodium Hyaluronate Eye Drop (sodium hyaluronate)

Snippet

Sponsor: Fang Duan | Conditions: Corneal Epithelium Exfoliation | Phase 3 | Status: UNKNOWN